Trial intelligence / Profile preview

New Tranexamic Acid Dosing Schedule for Cardiac Surgery

NCT00588133Phase 3Completed

Sponsor
Mayo Clinic
Start
Jan 2004
Primary completion
Dec 2007
Modality
Small Molecules
01

Overview

A Phase 3 trial of tranexamic acid in hemorrhage, sponsored by Mayo Clinic. Started Jan 2004; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT00588133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00588133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call